Delivery Order SPE2D018D0005-SPE2D325F9997

Award Date 4/16/25
Potential Completion Date 4/21/25
Potential Value $5.7K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with a ceiling value of $1,037.23, was issued by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company, for the provision of REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of November 25, 2024. Ortho-Clinical Diagnostics, Inc. is a for-profit organization and self-certified HUBZone joint venture that has previously...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer, to provide 150 ml of REAGENT ANTI-D BIOCLONE. The contract has a completion date of January 25, 2024 and a potential value of $1,037.23. Ortho-Clinical Diagnostics, Inc. is a for-profit organization and self-certified HUBZone joint venture that has previously provided medical equipment, reagents, and testing services to...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract worth $1,037.23 to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the supply of 150 ml vials of Reagent Anti-D Bioclone. The contract has a completion date of February 21, 2024. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that has provided a range of diagnostic solutions, including COVID-19 tests and immunodiagnostic equipment,...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company. The contract is for the delivery of 4566509432 - REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL, with a ceiling value of $1,037.23 and a completion date of November 26, 2024. Ortho-Clinical Diagnostics, Inc. is a for-profit organization and self-certified HUBZone joint venture that manufacturers a wide range...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for $1,037.23 to deliver 150ml vials of REAGENT ANTI-D BIOCLONE. The contract has a completion date of February 22, 2024. Ortho-Clinical Diagnostics is a self-certified HUBZone joint venture that has previously provided medical equipment, reagents, and testing services to several federal agencies, including the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company. The contract is for the procurement of 4566514571 - REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL, with a ceiling value of $1,037.23 and a completion date of November 26, 2024. The contract is not set aside for any specific business type. Ortho-Clinical Diagnostics, Inc. is a for-profit organization that is...
This is a delivery order awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $1,037.23 firm fixed price contract is for the supply of 150mL of Reagent Anti-D Bioclone, a critical diagnostic reagent used in blood banking operations. This award was made against a larger indefinite-delivery/indefinite-quantity contract held by Ortho-Clinical Diagnostics to support federal healthcare programs, including at the Department of...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer. The $1,037.23 firm fixed price delivery order is for the supply of 4566514555 REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL. The ultimate completion date for this contract is November 26, 2024. Ortho-Clinical Diagnostics has provided a range of medical equipment, reagents, and testing services to federal agencies...
This is a $1,037.23 firm fixed-price delivery order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the supply of 150 ml monoclonal anti-D reagent. The contract has an ultimate completion date of November 25, 2024 and does not utilize any set-aside designations. Ortho-Clinical Diagnostics is a provider of medical diagnostic solutions, including COVID-19 tests and immunodiagnostic/clinical chemistry analyzers, and...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Ortho-Clinical Diagnostics Inc., a medical equipment manufacturing company, to provide 150ml of Reagent Anti-D Bioclone. The contract has a completion date of December 27, 2023 and a potential value of $5,186.15. Ortho-Clinical Diagnostics Inc. is a for-profit organization and self-certified HUBZone joint venture that manufactures a range of diagnostic solutions, including analyzers,...
  • SPE2D018D0005
    Indefinite Delivery Contract
  • SPE2D018D0005-SPE2D325F9997
    Delivery Order

This is a federal contract award from the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $5,739.54 firm fixed-price delivery order is for the supply of 4567948697 REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 16, 2025. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and the contract does not utilize any set-aside designations. The company has a demonstrated history of providing specialized medical diagnostic equipment, reagents, and technical services to various federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, and DHA.

Generated 7/16/25, 12:09 PM